Ispire Technology (ISPR) vs Niagen Bioscience (NAGE)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 8, 2026.
Summary
Ispire Technology (ISPR) has outperformed Niagen Bioscience (NAGE) over the past year, losing 39.0% versus a loss of 62.1%. Niagen Bioscience is the larger company by market cap ($210.5 million vs $84.3 million), about 2.5 times the size. On valuation, Niagen Bioscience trades at a lower forward P/E (26.6x vs 73.0x for Ispire Technology).
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | ISPR | NAGE |
|---|---|---|
| Share price | $1.46 | $2.66 |
| Market cap | $84.32M | $210.48M |
| 1-day change | +3.55% | -2.21% |
| YTD return | -49.64% | -57.23% |
| 1-year return | -38.96% | -62.12% |
| 5-year return | — | -57.23% |
| P/E ratio (TTM) | — | 14.00 |
| Forward P/E | 73.00 | 26.60 |
| EPS (TTM) | $-0.58 | $0.19 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $3.87 | $7.95 |
| 52-week low | $1.01 | $2.61 |
| Distance from 52-week high | -62.27% | -66.54% |
| Analyst consensus | — | strong_buy |
| Avg. price target upside | — | +354.14% |
| Average volume | 35.98K | 585.78K |
| Shares outstanding | 57.75M | 79.13M |
| Employees | — | 117 |
| Sector | Health Care | Health Care |
| Industry | Medicinal Chemicals and Botanical Products | Medicinal Chemicals and Botanical Products |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- Niagen Bioscience is about 2.5 times larger than Ispire Technology by market value ($210.48M vs $84.32M).
- ISPR has outperformed NAGE by 23.2 percentage points over the past year.
About Niagen Bioscience
NAGE stock →Niagen Bioscience, Inc. operates as a bioscience company engages in developing healthy aging products.
Health Care · Medicinal Chemicals and Botanical Products · 117 employees
ISPR vs NAGE FAQ
Which is bigger, Ispire Technology or Niagen Bioscience?
Niagen Bioscience (NAGE) is larger, with a market capitalization of $210.48M compared with $84.32M for Ispire Technology (ISPR).
Which stock has performed better over the past year, ISPR or NAGE?
ISPR returned -38.96% over the past 12 months, compared with -62.12% for NAGE (price return, excluding dividends). Past performance does not predict future results.
Are Ispire Technology and Niagen Bioscience in the same industry?
Yes. Both are classified in the Medicinal Chemicals and Botanical Products industry within the Health Care sector.